Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus in Castration Resistant Metastatic Prostate Cancer
NCT00887640Phase 2Terminated
- Sponsor
- Duke University
- Start
- Jul 2009
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in prostate cancer (PCa), sponsored by Duke University. Started Jul 2009; status: terminated.
02
Drugs
temsirolimus
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00887640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00887640.